Skip to Content
Merck
CN
  • SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

The Journal of clinical investigation (2024-05-07)
Joan Sabadell-Basallote, Brenno Astiarraga, Carlos Castaño, Miriam Ejarque, Maria Repollés-de-Dalmau, Ivan Quesada, Jordi Blanco, Catalina Nuñez-Roa, M-Mar Rodríguez-Peña, Laia Martínez, Dario F De Jesus, Laura Marroqui, Ramon Bosch, Eduard Montanya, Francesc X Sureda, Andrea Tura, Andrea Mari, Rohit N Kulkarni, Joan Vendrell, Sonia Fernández-Veledo
ABSTRACT

Pancreatic β-cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here we report that the succinate receptor (SUCNR1) is expressed in β-cells and is up-regulated in hyperglycemic states in mice and humans. We found that succinate acts as a hormone-like metabolite and stimulates insulin secretion via a SUCNR1-Gq-PKC-dependent mechanism in human β-cells. Mice with β-cell-specific Sucnr1 deficiency exhibit impaired glucose tolerance and insulin secretion on a high-fat diet, indicating that SUCNR1 is essential for preserving insulin secretion in diet-induced insulin resistance. Patients with impaired glucose tolerance show an enhanced nutritional-related succinate response, which correlates with the potentiation of insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNR1 axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for insulin secretion relevant to the hyperinsulinemia of prediabetic states.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-β-Actin antibody, Mouse monoclonal, clone AC-15, purified from hybridoma cell culture